Hjem › Glioblastom › Colorado
Glioblastom kliniske forsøg i Colorado
14 studier for Glioblastom søger deltagere på steder i Colorado.
Byer i Colorado
Officiel studietekst (engelsk)
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- UCHealth University of Colorado Hospital, Aurora
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of Colorado Denver, Aurora
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT03970447Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- UCHealth, Aurora
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT05902169A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Colorado - Anschutz Medical Campus, Aurora
RekruttererFase 1/2
Op til 25 år · Alle køn · Opdateret 25. sep. 2026 · NCT04094610Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
- Saint Mary's Hospital and Regional Medical Center, Grand Junction
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT07452458A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
- Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's, Denver
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06914128Targeted Pediatric High-Grade Glioma Therapy
- Children's Hospital Colorado, Aurora
RekruttererObservationsstudie
12 Months – 39 Years · Alle køn · Opdateret 8. sep. 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Children's Hospital Colorado, Aurora
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 1. sep. 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Colorado Health Cancer Care, Aurora
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT05303519Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's Hospital Colorado, Aurora
RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
Alder 1 til 21 · Alle køn · Opdateret 29. jun. 2026 · NCT06333899A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- Sarah Cannon, SCRI Oncology Partners - Health One, Denver
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. jun. 2026 · NCT04678648The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
- University of Colorado Anschutz Medical Campus, Aurora
- University of Colorado Boulder, Boulder
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 9. jun. 2026 · NCT07636200Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's Hospital Colorado, Aurora
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 29. maj 2026 · NCT05843253SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Aurora
- Massive Bio SYNERGY-AI site, Denver
- Massive Bio SYNERGY-AI site, Littleton
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.